Md Richard Facs Kleiman Fort Lauderdale, FL - 33316

Md Richard Facs Kleiman is categorized under Orthopedic Doctors and Physicians in Fort Lauderdale, FL and active since 2007.

Md Richard Facs Kleiman was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Richard Kleiman at the company’s single location by writing to 721 Se 17th St, Fort Lauderdale, Florida FL 33316 or by phoning (954) 755-9049. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Md Richard Facs Kleiman
Contact Person: Richard Kleiman
Address: 721 Se 17th St, Fort Lauderdale, Florida 33316
Phone Number: (954) 755-9049
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Orthopedic Doctors and Physicians
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Md Richard Facs Kleiman was started in 2007 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Richard Kleiman for inquiries that concern Md Richard Facs Kleiman by calling the company number (954) 755-9049, as your correspondence is most welcome. Additionally, the physical location of the single location of Md Richard Facs Kleiman can be found at the coordinates 26.100495,-80.136224 as well as the street address 721 Se 17th St in Fort Lauderdale, Florida 33316.

For its online presence, you may visit Md Richard Facs Kleiman’s website at and engage with its social media outlets through on Twitter and on Facebook.